Alzheimer's disease (AD) is the most common cause of dementia in elderly people;
currently, there is no efficient treatment. Considering the increase in life expectancy …

The natural β-carboline alkaloids display similarities with neurotransmitters that can be
favorably exploited to design bioactive and bioavailable drugs for Alzheimer's disease (AD) …

Neurodegenerative diseases (ND), including Alzheimer's (AD) and Parkinson's Disease
(PD), are becoming increasingly more common and are recognized as a social problem in …

Alzheimer's disease (AD) is a neurological disorder that leads to dementia ie, progressive
memory loss accompanied with worsening of thinking ability of an individual. The cause of …

Alzheimer's disease (AD) is a complex, multifactorial and most prevalent progressive
neurodegenerative ailment. Its multifactorial and complex nature causes the lack of disease …

Due to the hugely important roles of neurotransmitter acetylcholine (ACh) and amyloid-β
(Aβ) in the pathogenesis of Alzheimer's disease (AD), the development of multi-target …

Alzheimer's disease (AD) is the most common form of dementia in elderly people with a high
incidence rate and complicated pathogenesis, and causes progressive cognitive deficit and …

The longstanding progressive neurodegenerative conditions of the central nervous system
arise mainly due to deterioration, degradation and eventual neuronal cell loss. As an …

Poly (ADP‐ribose) polymerase‐1 (PARP‐1) has been recognized as a prospective target for
the development of novel cancer therapeutics. Several PARP‐1 inhibitors are currently …

Infections caused by multidrug-resistant bacteria are becoming increasingly serious. The
aminoglycoside antibiotics have been widely used to treat severe Gram-negative bacterial …